Evidence map›Paper›PMID 27956707›Full record

ArticleMolecular & cellular proteomics : MCP2017

A Luciferase-fragment Complementation Assay to Detect Lipid Droplet-associated Protein-Protein Interactions.

Petra Kolkhof, Michael Werthebach, Anna van de Venn, Gereon Poschmann, Lili Chen, Michael Welte, Kai Stühler, Mathias Beller

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Apelin as a new therapeutic target for COVID-19 treatment.QJM : monthly journal of the Association of Physicians · 2023
    Article
  4. Article
  5. Article
  6. Frontiers in plant science · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Lipid droplet functions beyond energy storage.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2017
    Review
  13. Establishing the lipid droplet proteome: Mechanisms of lipid droplet protein targeting and degradation.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Petra KolkhofFrom the ‡Institute for Mathematical Modeling of Biological Systems, Heinrich Heine University, Duesseldorf, Germany.
Michael WerthebachFrom the ‡Institute for Mathematical Modeling of Biological Systems, Heinrich Heine University, Duesseldorf, Germany.
Anna van de VennFrom the ‡Institute for Mathematical Modeling of Biological Systems, Heinrich Heine University, Duesseldorf, Germany.
Gereon Poschmann¶Molecular Proteomics Laboratory, Institute for Molecular Medicine, Heinrich Heine University, Duesseldorf, Germany.
Lili Chen**Department of Biology, University of Rochester, Rochester, New York.
Michael Welte**Department of Biology, University of Rochester, Rochester, New York.
Kai Stühler¶Molecular Proteomics Laboratory, Institute for Molecular Medicine, Heinrich Heine University, Duesseldorf, Germany.
Mathias BellerFrom the ‡Institute for Mathematical Modeling of Biological Systems, Heinrich Heine University, Duesseldorf, Germany; mathias.beller@hhu.de.
Heinrich Heine University Düsseldorf · DEUniversity of Rochester · US

Funding

Lipid droplets as protein sequestration sitesR01GM102155 · NIGMS · UNIVERSITY OF ROCHESTER · PI WELTE, MICHAEL ANDREAS · 2013 to 2025
$4.2M
NIGMS NIH HHS R01 GM102155
6 · The paper itself

Abstract

A critical challenge for all organisms is to carefully control the amount of lipids they store. An important node for this regulation is the protein coat present at the surface of lipid droplets (LDs), the intracellular organelles dedicated to lipid storage. Only limited aspects of this regulation are understood so far. For the probably best characterized case, the regulation of lipolysis in mammals, some of the major protein players have been identified, and it has been established that this process crucially depends on an orchestrated set of protein-protein interactions. Proteomic analysis has revealed that LDs are associated with dozens, if not hundreds, of different proteins, most of them poorly characterized, with even fewer data regarding which of them might physically interact. To comprehensively understand the mechanism of lipid storage regulation, it will likely be essential to define the interactome of LD-associated proteins.Previous studies of such interactions were hampered by technical limitations. Therefore, we have developed a split-luciferase based protein-protein interaction assay and test for interactions among 47 proteins from Drosophila and from mouse. We confirmed previously described interactions and identified many new ones. In 1561 complementation tests, we assayed for interactions among 487 protein pairs of which 92 (19%) resulted in a successful luciferase complementation. These results suggest that a prominent fraction of the LD-associated proteome participates in protein-protein interactions.In targeted experiments, we analyzed the two proteins Jabba and CG9186 in greater detail. Jabba mediates the sequestration of histones to LDs. We successfully applied our split luciferase complementation assay to learn more about this function as we were

Indexed as

AnimalsCarboxylic Ester HydrolasesCarrier ProteinsDrosophila melanogasterDrosophila ProteinsHistonesLipid DropletsLuciferasesMiceProtein Interaction MappingProtein Interaction MapsUbiquitinationCarboxylic Ester HydrolasesCarrier ProteinsDrosophila ProteinsHistonesjabba protein, DrosophilaLuciferasessturkopf protein, Drosophila

Identifiers

PMID27956707
PMCPMC5340998
OpenAlexW2561667785

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.